JulieHuangDO(She/Her)

PubMed

• Safety and efficacy of oral anticoagulants in extreme weights.
  J Chin-Hon, L Davenport, M Akerman, A Hindenburg, Huang, J., J Huang> ;Thrombosis Research. 2023 Nov 1
• 2 citations
  Considerations for the Management of Oncology Patients During the COVID-19 Pandemic
  Julie Huang, Abhinav Rohatgi, Marc Justin Braunstein> ;Oncology. 2020 Oct 9
• 139 citations
  SPOP mutation leads to genomic instability in prostate cancer
  Gunther Boysen, Christopher E. Barbieri, Davide Prandi, Mirjam Blattner, Sung-Suk Chae, Arun Dahija, Srilakshmi Nataraj, Dennis Huang, Clarisse Marotz, Limei M. Xu, Ju...> ;Elife. 2015 Sep 16
• 36 citations
  Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk
  Francesca Demichelis, Sunita R. Setlur, Samprit Banerjee, Dimple Chakravarty, Jin Yun Helen Chen, Chen X. Chen, Julie Huang, Himisha Beltran, Derek A. Oldridge, Naoki ...> ;Proceedings of the National Academy of Sciences of the United States of America. 2012 Apr 24
• Join now to see all

Abstracts/Posters

• Neoadjuvant endocrine therapy (NET) as bridge therapy for early stage breast cancer during COVID 19: A single institution experience
  Julie Huang, Joshua Feinberg, Meredith Akerman, Anthony Pasquarella, Abhinav Rohatgi, Bahram Dabiri, Jordan Baum, Shubhada Dhage, Amber Guth, Nina D'Abreo, San Antonio Breast Cancer Symposium, San Antonio, TX, 12/2021
• Abstract P5-14-20: Neoadjuvant endocrine therapy (NET) during COVID-19: Single institution survey of patients’ perspectives
  Julie Huang, Joshua Feinberg, Meredith Akerman, Anthony Pasquarella, Abhinav Rohatgi, Bahram Dabiri, Jordan Baum, Shubhada Dhage, Amber Guth, Nina D'Abreo, San Antonio Breast Cancer Symposium, San Antonio, TX, 12/2021